Log In
Print
BCIQ
Print
Print this Print this
 

TRV027 (formerly TRV120027)

  Manage Alerts
Collapse Summary General Information
Company Trevena Inc.
DescriptionDual-acting ligand that inhibits angiotensin-mediated G-protein signaling and stimulates beta arrestin signaling via the angiotensin II type 1 (AT1) receptor (AGTR1)
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat acute decompensated heart failure (ADHF); Treat acute heart failure (AHF); Treat chronic heart failure; Treat heart failure
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today